Carayanniotis G, Barber B H
Department of Immunology, University of Toronto, Ontario, Canada.
Vaccine. 1990 Apr;8(2):137-44. doi: 10.1016/0264-410x(90)90136-a.
Having previously demonstrated that coupling protein antigens to anti-class II major histocompatibility complex (MHC) monoclonal antibodies provides a means of inducing adjuvant-independent IgG responses to the 'targeted' antigen, we have now explored the parameters of this response in more detail. Using as the model system egg avidin coupled to biotinylated anti-class II MHC mAbs, the kinetics of the avidin-specific 1 degrees IgG response, the IgG subclass distribution of the 2 degrees anti-avidin response, and the immunogenicity of anti-class II-avidin conjugates in H-2-recombinant mice have been investigated. In addition, the use of avidin as a bridging molecule in the creation of immunoconjugates involving third-party proteins has been further characterized, and the immunogenicity of defined soluble conjugates in mice bearing the appropriate class II MHC gene products has been demonstrated. These findings extend our understanding of the immunoconjugate approach to adjuvant-independent immunization, and support its exploration as an alternative means of subunit vaccine design.